Brief: Exelixis Announces Update On Second Patent Litigation Trial With MSN Laboratories

Exelixis

15/10/2024 18:58

Oct 15 (Reuters) - Exelixis Inc  EXEL.O :
    * EXELIXIS ANNOUNCES UPDATE ON SECOND PATENT LITIGATION
TRIAL WITH
MSN LABORATORIES
    * EXELIXIS INC - U.S. COURT RULES IN EXELIXIS' FAVOR IN
PATENT
LITIGATION AGAINST MSN
    * EXELIXIS INC - EARLIEST MSN CAN LAUNCH GENERIC
CABOZANTINIB IN
U.S. IS JAN 15, 2030
    * EXELIXIS INC - FDA HAS NOT YET GRANTED TENTATIVE APPROVAL
FOR
MSN'S GENERIC CABOZANTINIB
    * EXELIXIS INC - COURT RULED CO'S PHARMACEUTICAL COMPOSITION
PATENT NOT INVALID, NOT INFRINGED BY MSN

Source text for Eikon:  ID:nBw8nvvmXa 
Further company coverage:  EXEL.O 

 ((Reuters.Briefs@thomsonreuters.com;))